Foundation Models vs Physicians in Ophthalmological Questions

Foundation Models vs Physicians in Ophthalmological Questions

Interview with Darren Shu Jeng Ting, MBChB, PhD, author of Performance of Foundation Models vs Physicians in Textual and Multimodal Ophthalmological Questions. Hosted by Neil Bressler, MD.

Related Content:

Jaksot(127)

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

Interview with Johanna M. Seddon, MD, ScM, author of Validation of a Prediction Algorithm for Progression to Advanced Macular Degeneration Subtypes

14 Helmi 201311min

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

Interview with Ronald Klein, MD, MPH, author of Risk Alleles in CFH and ARMS2 and the Long-term Natural History of Age-Related Macular Degeneration

9 Marras 20126min

The Ophthalmic Practice of the Future

The Ophthalmic Practice of the Future

Interview with Marilyn B. Mets, MD, author of The Ophthalmic Practice of the Future.

10 Syys 201211min

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations

Interview with C. Jason Wang, MD, PhD, author of Improving Preterm Ophtalmologic Care in the Era of Accountable Care Organizations.

9 Heinä 201212min

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

Interview with Jonathan H. Lass, MD, author of Relationship of Fuchs Endothelial Corneal Dystrophy Severity to Central Corneal Thickness

9 Huhti 20126min

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

9 Tammi 20127min

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

Interview with Patricia Chévez-Barrios, MD, author of Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma

14 Marras 201110min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
tiedekulma-podcast
docemilia
rss-lihavuudesta-podcast
utelias-mieli
radio-antro
rss-ranskaa-raakana
rss-duodecim-lehti
rss-tervetta-skeptisyytta
university-of-eastern-finland
koodikahvit
vinkista-vihia
mielipaivakirja
filocast-filosofian-perusteet
rss-duokkari-ekstra
rss-paanavauksia
rss-astetta-parempi-elama-podcast
rss-metsantuntijat-podcast
rss-miljonaarien-tasavalta